M. McKenna

CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery

Jason M. Edmonds, W. Somers, Janet E. Paulsen, 2013, mAbs.

Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors

James R. Apgar, Liliana Wroblewska, L. Mosyak, 2021, mAbs.